Matinas BioPharma
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $962 | $0 |
Gross Profit | -124 | -85 | ||
EBITDA | -2,039 | -1,824 | -1,927 | |
EBIT | -2,150 | -1,837 | -1,946 | |
Net Income | -2,150 | -5,245 | -1,656 | -8,433 |
Net Change In Cash | 0 | 0 | 962 | 0 |
Free Cash Flow | -1,474 | -2,021 | -2,007 | -3,510 |
Cash | 5,435 | 6,525 | 6,924 | 7,284 |
Basic Shares | 5,435 | 5,086 | 5,086 | 5,086 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $1,096 | $3,188 | $33 |
Gross Profit | -972 | 1,096 | -13,490 | -14,550 |
EBITDA | -19,190 | -22,825 | -24,234 | -24,455 |
EBIT | -20,162 | -23,766 | -24,590 | -24,735 |
Net Income | -24,251 | -22,942 | -20,997 | -23,283 |
Net Change In Cash | 0 | 1,096 | 3,188 | 33 |
Cost of Revenue | -14,200 | 8,511 | ||
Free Cash Flow | -15,885 | -15,496 | -20,048 | -15,483 |
Cash | 7,284 | 4,787 | 6,880 | 21,030 |
Basic Shares | 4,865 | 4,345 | 4,336 | 4,203 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.40 |
2025-06-30 | -$1.03 |
2025-03-31 | -$0.81 |
2024-12-31 | -$0.80 |
